Recent News

• 06.05.2025 - Jefferies Global Healthcare Conference
• 06.05.2025 - Jefferies Global Healthcare Conference
• 05.29.2025 - Zenas BioPharma to Present at the Jefferies Global Healthcare Conference
• 05.29.2025 - Zenas BioPharma to Present at the Jefferies Global Healthcare Conference
• 05.15.2025 - Zenas BioPharma Reports First Quarter 2025 Financial Results and Provides Corporate Updates
• 05.15.2025 - Zenas BioPharma Reports First Quarter 2025 Financial Results and Provides Corporate Updates
• 04.17.2025 - Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 04.17.2025 - Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 04.07.2025 - Zenas BioPharma Appoints Haley Laken, Ph.D., as Chief Scientific Officer
• 04.07.2025 - Zenas BioPharma Appoints Haley Laken, Ph.D., as Chief Scientific Officer

Recent Filings

• 05.15.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.15.2025 - EX-99.1 EX-99.1
• 05.15.2025 - 8-K Current report
• 05.12.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 04.28.2025 - DEF 14A Other definitive proxy statements
• 04.28.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.28.2025 - 4/A Statement of changes in beneficial ownership of securities
• 04.28.2025 - ARS Annual Report to Security Holders
• 04.17.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.01.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors